BET inhibition decreases HMGCS2 and sensitizes resistant pancreatic tumors to gemcitabine
- Aubrey L. Miller
- , Samuel C. Fehling
- , Rebecca B. Vance
- , Dongquan Chen
- , Eric Josh Brown
- , M. Iqbal Hossain
- , Eric O. Heard
- , Shaida A. Andrabi
- , Hengbin Wang
- , Eddy S. Yang
- , Donald J. Buchsbaum
- , Robert C.A.M. van Waardenburg
- , Susan L. Bellis
- , Karina J. Yoon
Research output: Contribution to journal › Article › peer-review
13
Scopus
citations